{"title":"Advances in tissue-type imaging (TTI) for detecting and evaluating prostate cancer","authors":"E. Feleppa, S. Urban, A. Kalisz, C. R. Porter","doi":"10.1109/ULTSYM.2002.1192551","DOIUrl":null,"url":null,"abstract":"We are seeking to apply advanced ultrasonic tissue typing methods to overcoming severe limitations that now exist in conventional means of imaging cancerous lesions of the prostate. New tissue-type imaging (TTI) methods based on spectrum analysis of radiofrequency (RF) echo signals and neural-network classifiers show potential for distinguishing cancerous from non-cancerous prostate tissues. Encouraging ROC-curve results indicate superior classification. Consequently, these new TTI images may improve biopsy guidance and therapy targeting so that cancers are more-effectively detected and treated.","PeriodicalId":378705,"journal":{"name":"2002 IEEE Ultrasonics Symposium, 2002. Proceedings.","volume":"110 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2002-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2002 IEEE Ultrasonics Symposium, 2002. Proceedings.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ULTSYM.2002.1192551","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
We are seeking to apply advanced ultrasonic tissue typing methods to overcoming severe limitations that now exist in conventional means of imaging cancerous lesions of the prostate. New tissue-type imaging (TTI) methods based on spectrum analysis of radiofrequency (RF) echo signals and neural-network classifiers show potential for distinguishing cancerous from non-cancerous prostate tissues. Encouraging ROC-curve results indicate superior classification. Consequently, these new TTI images may improve biopsy guidance and therapy targeting so that cancers are more-effectively detected and treated.